P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response.

SEMERÁD, Lukáš, Daniela ŽÁČKOVÁ, Petra BĚLOHLÁVKOVÁ, Jaroslava VOGLOVÁ, Pavel ŽÁK, Edgar FABER, Tomáš PAPAJÍK, I. SKOUMALOVÁ, M. KARAS, P. JINDRA, H. KLAMOVÁ, C. ŠÁLEK, D. SRBOVÁ, H. ŽIŽKOVÁ, L. STEJSKAL, Olga ČERNÁ, Eduard CMUNT, Petra ČIČÁTKOVÁ, Anežka KVETKOVÁ, Tomáš HORŇÁK, Ivana JEŽÍŠKOVÁ, Tomáš JURČEK, Barbora WEINBERGEROVÁ, Jiřina PROCHÁZKOVÁ, Kateřina MACHOVÁ POLÁKOVÁ, Adam SVOBODNÍK, Radka ŠTĚPÁNOVÁ and Jiří MAYER. P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response. In EHA 2023 in HemaSphere (2023). 2023.

Basic information

• Original name: P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response.
• Authors: SEMERÁD, Lukáš (203 Czech Republic, belonging to the institution), Daniela ŽÁČKOVÁ (203 Czech Republic, belonging to the institution), Petra BĚLOHLÁVKOVÁ (203 Czech Republic, belonging to the institution), Jaroslava VOGLOVÁ (203 Czech Republic, belonging to the institution), Pavel ŽÁK (203 Czech Republic, belonging to the institution), Edgar FABER (703 Slovakia, belonging to the institution), Tomáš PAPAJÍK (203 Czech Republic, belonging to the institution), I. SKOUMALOVÁ (203 Czech Republic), M. KARAS, P. JINDRA, H. KLAMOVÁ, C. ŠÁLEK, D. SRBOVÁ, H. ŽIŽKOVÁ, L. STEJSKAL, Olga ČERNÁ (203 Czech Republic), Eduard CMUNT (203 Czech Republic, belonging to the institution), Petra ČIČÁTKOVÁ (203 Czech Republic, belonging to the institution), Anežka KVETKOVÁ (703 Slovakia, belonging to the institution), Tomáš HORŇÁK (703 Slovakia, belonging to the institution), Ivana JEŽÍŠKOVÁ (203 Czech Republic, belonging to the institution), Tomáš JURČEK (203 Czech Republic, belonging to the institution), Barbora WEINBERGEROVÁ (203 Czech Republic, belonging to the institution), Jiřina PROCHÁZKOVÁ (203 Czech Republic, belonging to the institution), Kateřina MACHOVÁ POLÁKOVÁ (203 Czech Republic, belonging to the institution), Adam SVOBODNÍK (203 Czech Republic, belonging to the institution), Radka ŠTĚPÁNOVÁ (203 Czech Republic, belonging to the institution) and Jiří MAYER (203 Czech Republic, belonging to the institution).
• Edition: EHA 2023 in HemaSphere (2023), 2023.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 30205 Hematology
• Country of publisher: Germany
• Confidentiality degree: is not subject to a state or trade secret
• RIV identification code: RIV/00216224:14110/23:00131051
• Organization unit: Faculty of Medicine
• Keywords in English: CML; TKI treatment; deep molecular response
• Tags: rivok
• Tags: International impact

Abstract

Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response - EHA 2023 in HemaSphere (2023) conference abstract.

Links

• LM2023049, research and development project: Name: Český národní uzel Evropské sítě infrastruktur klinického výzkumu

Investor: Ministry of Education, Youth and Sports of the CR

• LX22NPO5102, research and development project: Name: Národní ústav pro výzkum rakoviny (Acronym: NÚVR)

Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES